Literature DB >> 17954229

Lipidomics in diabetes and the metabolic syndrome.

Richard W Gross1, Xianlin Han.   

Abstract

Shotgun lipidomics, based on multi-dimensional mass spectrometric array analyses after multiplexed sample preparation and intrasource separation, has been recently advanced to a mature technique for the rapid and reproducible global analysis of cellular lipids. At its current stage, this technology enables us to analyze more than 20 lipid classes and thousands of individual lipid molecular species directly from lipid extracts of biologic samples. Following a brief introduction to the foundations underlying this rapidly expanding technology, we present detailed protocols used for the identification and quantitation of plasma triglycerides, determination of the human heart lipidome, and analysis of cellular cardiolipin molecular species. Through the use and practice of shotgun lipidomics, new insights into the cardiovascular pathobiology manifest in diabetes and the metabolic syndrome can be accrued.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954229     DOI: 10.1016/S0076-6879(07)33004-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  19 in total

Review 1.  First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

Authors:  Hazel H Szeto
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Shotgun lipidomics on high resolution mass spectrometers.

Authors:  Dominik Schwudke; Kai Schuhmann; Ronny Herzog; Stefan R Bornstein; Andrej Shevchenko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

3.  Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families.

Authors:  Hemant Kulkarni; Peter J Meikle; Manju Mamtani; Jacquelyn M Weir; Marcio Almeida; Vincent Diego; Juan Manuel Peralta; Christopher K Barlow; Claire Bellis; Thomas D Dyer; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; Harald H H Göring; Joanne E Curran; John Blangero
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

4.  Development of an automated multi-injection shotgun lipidomics approach using a triple quadrupole mass spectrometer.

Authors:  John A Bowden; Jackie T Bangma; John R Kucklick
Journal:  Lipids       Date:  2014-04-12       Impact factor: 1.880

Review 5.  Lipidomics in the Study of Hypertension in Metabolic Syndrome.

Authors:  Hemant Kulkarni; Manju Mamtani; John Blangero; Joanne E Curran
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

6.  Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics.

Authors:  Kelly M Hines; Josi Herron; Libin Xu
Journal:  J Lipid Res       Date:  2017-02-06       Impact factor: 5.922

7.  A reversed-phase capillary ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) method for comprehensive top-down/bottom-up lipid profiling.

Authors:  Xiaoli Gao; Qibin Zhang; Da Meng; Giorgis Isaac; Rui Zhao; Thomas L Fillmore; Rosey K Chu; Jianying Zhou; Keqi Tang; Zeping Hu; Ronald J Moore; Richard D Smith; Michael G Katze; Thomas O Metz
Journal:  Anal Bioanal Chem       Date:  2012-02-23       Impact factor: 4.142

Review 8.  Lipidomics for studying metabolism.

Authors:  Xianlin Han
Journal:  Nat Rev Endocrinol       Date:  2016-07-29       Impact factor: 43.330

9.  Nystatin interferes with the effects of N-methyl-N'-nitro-N-nitrosoguanidine on sphingolipid metabolism in human FL cells.

Authors:  Guangyi Liu; Weimin Wang; Gongping Sun; Xiaoqiong Ma; Ziyang Liu; Jun Yang
Journal:  Lipids       Date:  2008-07-15       Impact factor: 1.880

10.  Aliphatic chain length by isotropic mixing (ALCHIM): determining composition of complex lipid samples by ¹H NMR spectroscopy.

Authors:  Joseph R Sachleben; Ruiyang Yi; Paul A Volden; Suzanne D Conzen
Journal:  J Biomol NMR       Date:  2014-05-15       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.